Liu Yi, Rao Ushnal, McClure Jan, Konopa Philip, Manocheewa Siriphan, Kim Moon, Chen Lennie, Troyer Ryan M, Tebit Denis M, Holte Sarah, Arts Eric J, Mullins James I
Department of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America.
PLoS One. 2014 Apr 8;9(4):e94240. doi: 10.1371/journal.pone.0094240. eCollection 2014.
It has been hypothesized that a single mutation at a highly conserved amino acid site (HCS) can be severely deleterious to HIV in most if not all isolate-specific genetic backgrounds. Consequently, potentially universal HIV-1 vaccines exclusively targeting highly conserved regions of the viral proteome have been proposed. To test this hypothesis, we examined the impact of 10 Gag-p24 and 9 Env-gp120 HCS single mutations on viral fitness. In the original founder sequence of the subject in whom these mutations were identified, all Gag-p24 HCS mutations significantly reduced viral replication fitness, including 7 that were lethal. Similar results were obtained at 9/10 sites when the same mutations were introduced into the founder sequences of two epidemiologically unlinked subjects. In contrast, none of the 9 Env-gp120 HCS mutations were lethal in the original founder sequence, and four had no fitness cost. Hence, HCS mutations in Gag-p24 are likely to be severely deleterious in different HIV-1 subtype B backgrounds; however, some HCS mutations in both Gag-p24 and Env-gp120 fragments can be well tolerated. Therefore, when designing HIV-1 immunogens that are intended to force the virus to nonviable escape pathways, the fitness constraints on the HIV segments included should be considered beyond their conservation level.
据推测,在高度保守的氨基酸位点(HCS)发生的单个突变,即便不是在所有特定分离株的遗传背景中,也极有可能对HIV具有严重的有害作用。因此,有人提出专门针对病毒蛋白质组高度保守区域的潜在通用型HIV-1疫苗。为了验证这一假设,我们研究了10个Gag-p24和9个Env-gp120 HCS单突变对病毒适应性的影响。在发现这些突变的受试者的原始奠基者序列中,所有Gag-p24 HCS突变均显著降低了病毒复制适应性,其中7个是致死性的。当将相同突变引入两个流行病学上无关联的受试者的奠基者序列时,在10个位点中的9个位点也得到了类似结果。相比之下,9个Env-gp120 HCS突变在原始奠基者序列中均无致死性,且有4个突变对适应性没有影响。因此,Gag-p24中的HCS突变在不同的HIV-1 B亚型背景中可能具有严重的有害作用;然而,Gag-p24和Env-gp120片段中的一些HCS突变可以被很好地耐受。所以,在设计旨在迫使病毒进入不可行逃逸途径的HIV-1免疫原时,除了考虑其保守水平外,还应考虑所包含的HIV片段的适应性限制。